Cargando…
Modified FOLFIRINOX for resected pancreatic cancer: Opportunities and challenges
Pancreatic cancer is one of the leading causes of cancer death worldwide. Adjuvant chemotherapy has been developed based on the experiences made with palliative chemotherapy, and advocated to improve long-term survival of patients with this disease. However, the optimal chemotherapeutic regimen rema...
| Autores principales: | , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Baishideng Publishing Group Inc
2019
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6589737/ https://www.ncbi.nlm.nih.gov/pubmed/31249443 http://dx.doi.org/10.3748/wjg.v25.i23.2839 |